scispace - formally typeset
H

Hideki Iwaguro

Researcher at Tokai University

Publications -  18
Citations -  5513

Hideki Iwaguro is an academic researcher from Tokai University. The author has contributed to research in topics: Progenitor cell & Endothelial stem cell. The author has an hindex of 12, co-authored 15 publications receiving 5429 citations. Previous affiliations of Hideki Iwaguro include Tufts University.

Papers
More filters
Journal ArticleDOI

VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells

TL;DR: A novel role is established for VEGF in postnatal neovascularization which complements its known impact on angiogenesis and is based on data from animal models and human subjects.
Journal ArticleDOI

Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia

TL;DR: Ex vivo expanded EPCs incorporate into foci of myocardial neovascularization and have a favorable impact on the preservation of left ventricular function.
Journal ArticleDOI

Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia

TL;DR: In this article, the authors investigated whether catheter-based, intramyocardial transplantation of autologous endothelial progenitor cells can enhance neovascularization in myocardial ischemia.
Journal ArticleDOI

Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular Regeneration

TL;DR: In vivo, gene-modified EPCs facilitate the strategy of cell transplantation to augment naturally impaired neovascularization in an animal model of experimentally induced limb ischemia.
Journal ArticleDOI

Vascular Endothelial Growth Factor165 Gene Transfer Augments Circulating Endothelial Progenitor Cells in Human Subjects

TL;DR: The hypothesis that VEGF gene transfer may also augment the population of circulating endothelial progenitor cells (EPCs) supports the notion that neovascularization of human ischemic tissues after angiogenic growth factor therapy is not limited to angiogenesis but involves circulate endothelial precursors that may home to isChemic foci and differentiate in situ through a process of vasculogenesis.